← Eichor
Condition: Chemotherapy Induced Nausea And Vomiting Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chemotherapy Induced Nausea And Vomiting

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer
Phase N/A · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT05830279
Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Brea
Phase N/A · 5 location(s) · Mayo Clinic · NCT05417867
Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Phase 3 · 1 location(s) · Augusta University · NCT06588413
Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07726433
Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies
NA · 4 location(s) · University Hospital, Limoges · NCT06150469
Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
Phase N/A · 1 location(s) · Anhui Provincial Children's Hospital · NCT06756022
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Phase 3 · 1 location(s) · Feixue Song · NCT06314906
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
Phase 2 · 10 location(s) · The Hospital for Sick Children · NCT03118986
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Phase 2 · 67 location(s) · Eli Lilly and Company · NCT07169851
Vomiting Prevention in Children With Cancer
NA · 1 location(s) · The Hospital for Sick Children · NCT06886451
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paedia
Phase 2 · 20 location(s) · Helsinn Healthcare SA · NCT06904235
Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin
Phase 2 · 1 location(s) · Mahidol University · NCT07699276
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
NA · 1 location(s) · Baskent University · NCT06120764
An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing
Phase 4 · 1 location(s) · Shanghai 6th People's Hospital · NCT07482891
BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron
Phase 4 · 1 location(s) · University of Illinois at Chicago · NCT04150614
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
NA · 2 location(s) · University of Central Florida · NCT05838638
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
Phase 3 · 1 location(s) · Jiuda Zhao · NCT06200168
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Phase 3 · 1 location(s) · Fudan University · NCT06017284
Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile
Phase 2 · 1 location(s) · Chinese University of Hong Kong · NCT07455955
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compar
Phase 3 · 1 location(s) · Yizhuo Zhang · NCT06208917
Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Bloc
NA · 1 location(s) · Hubei Cancer Hospital · NCT06080880
Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy
Phase 3 · 1 location(s) · Mahidol University · NCT06850454
Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regim
Phase 3 · 1 location(s) · The Affiliated People's Hospital of Ningbo University · NCT07413809
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.